Skip to main content
HighlightsHighlights Archive

Media Monitoring: 11 – 17 January

Report: NHS Supply Chain and efficiencies in procurement The NHS is not maximising its spending power to save money when purchasing medical equipment and consumables, according to a new National Audit Office (NAO) report. The report found that the NHS continued to spend more than £3 billion outside NHS Supply Chain, its purpose-built procurement route, as customer satisfaction with Supply…
Dawn
January 17, 2024
HighlightsHighlights Archive

Scientists develop test which can detect 18 early-stage cancers

Scientists have developed a test which is able to detect 18 early-stage cancers, which has been hailed by experts as a key step towards improving the early detection of cancer in a highly accurate, non-invasive way. Often existing methods for screening are invasive and more costly, meaning this new test represents huge progress in diagnosing cancer in a more effective…
Dawn
January 17, 2024
HighlightsHighlights Archive

Landmark national study supports use of whole genome sequencing in standard cancer care

In the largest study of its kind, scientists report how combining health data with whole genome sequence (WGS) data in patients with cancer can help doctors provide more tailored care for their patients. The research, published in Nature Medicine, shows that linking WGS data to real-world clinical data can identify changes in cancer DNA that may be relevant for an individual…
Dawn
January 17, 2024
HighlightsHighlights Archive

Media Monitoring

NHS England trials home testing for Chronic Kidney Disease. Tens of thousands of patients at risk of kidney disease will be able to get tested from the comfort of their own homes as part of a £30 million tech and AI innovation fund this winter. The Healthy.io early detection device will initially be sent to 30,000 patients who are considered…
Dawn
January 10, 2024
HighlightsHighlights Archive

MHRA Roadmap

A new MedTech roadmap published by the MHRA The MHRA have today published a roadmap towards the future regulatory framework for medical devices. This sets out their planned activities into 2025. The roadmap is intended to deliver greater international harmonisation, with more patient-centred, proportionate requirements for medical devices which are responsive to technological advances. Dr Laura Squire, the MHRA’s MedTech Regulatory Reform…
Dawn
January 10, 2024
HighlightsHighlights Archive

Springboard Launch

BIVDA are excited to announce our collaboration with Barclays Eagle Labs to deliver the Springboard Programme in 2024. The BIVDA Springboard Programme is intended to help our innovative new member companies grow and develop by collaborating and connecting with leading industry experts.  The programme is designed to facilitate the understanding of the IVD market in the UK and beyond by…
Dawn
January 10, 2024
HighlightsHighlights Archive

Media Monitoring

The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis (The Lancet) This study reveals a high level of AMR burden for several bacterial pathogens and pathogen–drug combinations in the WHO African region. The high mortality rates associated with these pathogens demonstrate an urgent need to address the burden of AMR in Africa.…
Dawn
January 3, 2024
HighlightsHighlights Archive

New monthly MHRA newsletter

The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, medical devices and blood components for transfusion in the UK. Subscribe to their new monthly newsletter to stay updated on their activities.
Dawn
January 3, 2024
HighlightsHighlights Archive

Hundreds of thousands more people will be sent a home-testing kit that can help to detect signs of bowel cancer, as the NHS expands its lifesaving screening programme to individuals aged 54 in England. (NHSE)

People aged 54 will now automatically receive a home test kit every two years by post when they become eligible. The kit, known as the faecal immunochemical test (FIT), checks for blood in a small stool sample, which can be a sign of bowel cancer. The phased expansion to people aged 54 years means an additional 830,000 people in England…
Dawn
January 3, 2024
HighlightsHighlights Archive

Breakthrough’ blood test for sepsis to save lives (The Times paywall)

A blood test is being trialled that can rapidly detect whether a patient has sepsis, in what could be a breakthrough for sepsis diagnosis and treatment.  Sepsis is a notoriously difficult condition to diagnose and early intervention significantly improves patient outcomes. Dr Andrew Retter, an intensive care consultant at Guy’s and St Thomas’ NHS Foundation Trust in London, who is…
Dawn
January 3, 2024